Tel:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@anticorps-enligne.fr

SSX2 anticorps (C-Term)

L’anticorps Lapin Polyclonal anti-SSX2 a été validé pour WB. Il convient pour détecter SSX2 dans des échantillons de Humain.
N° du produit ABIN927674

Aperçu rapide pour SSX2 anticorps (C-Term) (ABIN927674)

Antigène

Voir toutes SSX2 Anticorps
SSX2 (Synovial Sarcoma, X Breakpoint 2 (SSX2))

Reactivité

  • 47
  • 3
  • 2
Humain

Hôte

  • 41
  • 6
Lapin

Clonalité

  • 44
  • 3
Polyclonal

Conjugué

  • 19
  • 3
  • 2
  • 2
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
Cet anticorp SSX2 est non-conjugé

Application

  • 32
  • 13
  • 13
  • 9
  • 5
  • 5
  • 5
  • 4
  • 3
  • 1
  • 1
Western Blotting (WB)
  • Épitope

    • 15
    • 7
    • 6
    • 3
    • 2
    • 2
    • 1
    • 1
    C-Term

    Purification

    Purified

    Immunogène

    SSX2 antibody was raised in rabbit using the C terminal of SSX2 as the immunogen
  • Indications d'application

    WB: 0.2-1 µg/mL
    Optimal conditions should be determined by the investigator.

    Commentaires

    SSX2 Blocking Peptide, (ABIN939235), is also available for use as a blocking control in assays to test for specificity of this SSX2 antibody

    Restrictions

    For Research Use only
  • Format

    Lyophilized

    Concentration

    Lot specific

    Buffer

    Lyophilized powder. Add 50 µL of distilled water. Final antibody concentration is 1 mg/mL in PBS buffer.

    Conseil sur la manipulation

    Avoid repeated freeze/thaw cycles.

    Stock

    4 °C/-20 °C

    Stockage commentaire

    Store at 4 °C, following reconstitution, aliquot and store at -20 °C.
  • Antigène

    SSX2 (Synovial Sarcoma, X Breakpoint 2 (SSX2))

    Autre désignation

    SSX2

    Sujet

    SSX2 belongs to the family of highly homologous synovial sarcoma X (SSX) breakpoint proteins. These proteins may function as transcriptional repressors. They are also capable of eliciting spontaneously humoral and cellular immune responses in cancer patients, and are potentially useful targets in cancer vaccine-based immunotherapy. SSX1, SSX2 and SSX4 genes have been involved in the t(X,18) translocation characteristically found in all synovial sarcomas. This translocation results in the fusion of the synovial sarcoma translocation gene on chromosome 18 to one of the SSX genes on chromosome X. The encoded hybrid proteins are probably responsible for transforming activity. Two transcript variants encoding distinct isoforms have been identified for this gene. Synonyms: Polyclonal SSX2 antibody, Anti-SSX2 antibody, synovial sarcoma, X breakpoint 2 antibody, HD21 antibody, HOM-MEL-40 antibody, MGC119055 antibody, MGC15364 antibody, MGC3884 antibody, SSX antibody.
Vous êtes ici:
Chat with us!